Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2018

Oct 19, 2018

SELL
$21.06 - $25.65 $389,610 - $474,525
-18,500 Closed
0 $0
Q2 2018

Jul 13, 2018

BUY
$16.77 - $24.71 $34,378 - $50,655
2,050 Added 12.46%
18,500 $449,000
Q1 2018

May 11, 2018

BUY
$16.68 - $22.07 $4,170 - $5,517
250 Added 1.54%
16,450 $282,000
Q4 2017

Feb 14, 2018

SELL
$11.23 - $19.1 $16,845 - $28,650
-1,500 Reduced 8.47%
16,200 $307,000
Q3 2017

Oct 19, 2017

BUY
$15.41 - $32.17 $272,757 - $569,409
17,700
17,700 $311,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $25.1B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Guardian Investment Management Portfolio

Follow Guardian Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Guardian Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Guardian Investment Management with notifications on news.